Skip to main content

Aziz Mottiwala

Equibles does not estimate personal net worth.

About Aziz Mottiwala

The proxy statement of Tarsus Pharmaceuticals, Inc. reports total compensation of $3,138,862 for Aziz Mottiwala in fiscal 2024, including a base salary of $492,633. Aziz Mottiwala has spoken on 4 earnings calls and 4 other investor events across 1 company, most recently for Tarsus Pharmaceuticals, Inc. on June 3, 2026. The companies whose calls Aziz Mottiwala spoke on are classified in the Healthcare sector.

Aziz Mottiwala on recent calls

“I'd say we've made a lot of progress but I think there's still a lot of opportunity here when you think about the fact that we've had over 20,000 doctors write this that's a lot of behaviors to change and to me that's exciting I mean to be at a point where our guidance for this year is 670 to 700 million and to say…”
Other, Jefferies Global Healthcare Conference in New York ·
“Thanks so much and appreciate the opportunity to be here and talk a little bit about our story. As you mentioned, Tarsus is based in Southern California. We're commercial stage.”
Other, Stifel 2026 Virtual Ophthalmology Conference ·
“So this is a really great time for us in terms of, as Jeff mentioned, once we work through this Q1 seasonality, the underlying business, all the factors here look really positive and progressed nicely in Q1.”
Other, Bank of America Securities 2026 Health Care Conference ·
“So this is a really great time for us in terms of, as Jeff mentioned, once we work through this Q1 seasonality, the underlying business, all the factors here look really positive and progressed nicely in Q1.”
Other, Bank of America Securities 2026 Health Care Conference ·
“As just highlighted, in Q1, we delivered more than $145 million in extending net product sales, an increase of more than 85% year-over-year, and we meaningfully outperformed the market.”
Other, Tarsus Pharmaceuticals, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Tarsus Pharmaceuticals, Inc. (TARS) $492,633 $3,138,862

Recent activity